Chengdu Easton Biopharmaceuticals Dividends and Buybacks
Dividend criteria checks 3/6
Chengdu Easton Biopharmaceuticals is a dividend paying company with a current yield of 1.14% that is well covered by earnings.
Key information
1.1%
Dividend yield
-0.6%
Buyback Yield
Total Shareholder Yield | 0.6% |
Future Dividend Yield | 3.0% |
Dividend Growth | 22.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.395 |
Payout ratio | 28% |
Recent dividend and buyback updates
Recent updates
Concerns Surrounding Chengdu Easton Biopharmaceuticals' (SHSE:688513) Performance
Nov 01There Is A Reason Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Price Is Undemanding
Jul 23Why Chengdu Easton Biopharmaceuticals' (SHSE:688513) Shaky Earnings Are Just The Beginning Of Its Problems
May 01Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Share Price Matching Investor Opinion
Mar 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 688513 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 688513's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
Chengdu Easton Biopharmaceuticals Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (688513) | 1.1% |
Market Bottom 25% (CN) | 0.5% |
Market Top 25% (CN) | 2.1% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (688513) (up to 3 years) | 3.0% |
Notable Dividend: 688513's dividend (1.14%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 688513's dividend (1.14%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (27.7%), 688513's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (62.6%), 688513's dividend payments are covered by cash flows.